However, in advanced-stage cancer, TGF-β has the potential to promote many of the malignant features of GB, such as migration/invasion, angiogenesis, immunosuppression, and drug resistance/radioresistance [63,64,65,66]. This evidence concerns the gene TGFB1 and cancer.